Antheia Announces $40M in Debt Financing and Plans to Construct Pilot Plant Facility for Biomanufacturing
MENLO PARK, Calif., June 22, 2022 /PRNewswire/ — Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, today announced $40 million in venture debt financing from Oxford Finance LLC and Silicon Valley Bank, alongside plans to construct a new pilot scale biomanufacturing facility. The financing will support Antheia’s expansion with a 14,700 square-foot…Read More
Read MoreDigiLens Completes Second Close of Its Series D $50M Funding
Sunnyvale, CA – April 7, 2022: DigiLens Inc., an innovator in head worn holographic display and waveguide technology, today announced that Corning Incorporated has joined its Series D funding round as an investor. FLG partner Eric Mersch assisted. Corning joins a diverse and impressive list of investors in this round that…Read More
Read MoreSoleno Therapeutics Raises $15M in Under Written Public Offering
REDWOOD CITY, Calif., April 01, 2022 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced the closing of an underwritten public offering of 40,000,000 shares of its common stock at a public offering price of…Read More
Read MoreApexigen and Brookline Capital Acquisition Corp. Create Publicly Listed Immuno-oncology Company via SPAC
SAN CARLOS, CA, and NEW YORK, NY, March 18, 2022 – Apexigen, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for oncology, and Brookline Capital Acquisition Corp. (Nasdaq: BCAC, BCACU, BCACW), a special purpose acquisition company (“SPAC”), today announced they have entered…Read More
Read MoreCitcon USA, LLC Engages FLG Partners
Citcon, a global all-in-one in-store, online, and mobile payment platform based in Silicon Valley has engaged FLG partner Bill Beyer.
Read More
Recent News
